Zeng Hao, You Cong, Zhao Leran, Wang Jiangyi, Ye Xiaoying, Yang Tao, Wan Chunlei, Deng Longying
Department of Burn and Plastic Surgery, Ganzhou People's Hospital, The Affiliated Ganzhou Hospital of Nanchang University, Ganzhou, China.
Department of Dermatology and Venereology, Candidate Branch of National Clinical Research Centre for Skin and Immune Diseases, The First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
J Oncol. 2021 Oct 28;2021:3658196. doi: 10.1155/2021/3658196. eCollection 2021.
Ferroptosis plays a critical role in different types of cancers, but the prognostic impact of ferroptosis in cutaneous melanoma remains lacking. Therefore, ferroptosis-related genes (FRGs) were firstly obtained from the FerrDb database and the differentially expressed FRGs were identified by the "limma" algorithm. Next, the prognostic differentially expressed FRGs were screened out by univariate Cox regression, which were subsequently used to cluster melanomas into two subtypes (clusters A and B). Besides, the Boruta algorithm and principal component analysis (PCA) were performed to build a 15-FRGs indicator, which can robustly predict patients' overall survival (OS) and be considered as an independent prognostic factor in melanoma. The melanoma patients were further divided into high- and low-FRGs score groups. The high score group have a good prognosis, with higher T cell immune infiltrating and lower mutation frequencies in NRAS, KRAS, and NF1. Finally, we discovered that many immune processes and several chemotherapy drugs were closely associated with FRGs score. Thus, our study provides a novel ferroptosis-associated classifier and indicator to predict the prognosis of melanoma. Besides, we identified several potential chemotherapy drugs to induce ferroptosis and could supply additional effective treatments.
铁死亡在不同类型的癌症中起着关键作用,但铁死亡在皮肤黑色素瘤中的预后影响仍不清楚。因此,首先从FerrDb数据库中获取铁死亡相关基因(FRGs),并通过“limma”算法识别差异表达的FRGs。接下来,通过单变量Cox回归筛选出预后差异表达的FRGs,随后用于将黑色素瘤分为两个亚型(A组和B组)。此外,采用Boruta算法和主成分分析(PCA)构建了一个15-FRGs指标,该指标可以可靠地预测患者的总生存期(OS),并被认为是黑色素瘤的独立预后因素。黑色素瘤患者进一步分为高FRGs评分组和低FRGs评分组。高分组合有较好的预后,T细胞免疫浸润较高,NRAS、KRAS和NF1的突变频率较低。最后,我们发现许多免疫过程和几种化疗药物与FRGs评分密切相关。因此,我们的研究提供了一种新的铁死亡相关分类器和指标来预测黑色素瘤的预后。此外,我们确定了几种潜在的诱导铁死亡的化疗药物,并可以提供额外的有效治疗方法。